Actively Recruiting
Real World Study of Classic Infectious Disease
Led by Huashan Hospital · Updated on 2020-05-14
10000
Participants Needed
1
Research Sites
472 weeks
Total Duration
On this page
Sponsors
H
Huashan Hospital
Lead Sponsor
F
First Affiliated Hospital of Xinjiang Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aimed to collect and analyze clinical specimens of patients with classic infectious diseases in the real world. To investigate the epidemiological distribution of classic infectious diseases (brucellosis, epidemic hemorrhagic fever, kala-azar) and treatment options suitable for China.
CONDITIONS
Official Title
Real World Study of Classic Infectious Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with confirmed brucellosis by sample culture or specific antigen/antibody positive
- Patients with epidemic hemorrhagic fever confirmed by specific antibody or Hantavirus RNA positive
- Patients with latent kala-azar infection confirmed by rK39 antibody positive
- Patients diagnosed with kala-azar by bone marrow or spleen sample culture, smear, or clinical symptoms with positive screening test
- Adults aged 18 to 75 years
You will not qualify if you...
- Incomplete patient history data
- HIV antibody positive or AIDS patients
- Participation in other clinical trials during the same period
- Pregnant or lactating women, or women of childbearing age planning to conceive
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Huashan Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 200040
Actively Recruiting
Research Team
J
JingWen Ai, Doctor
CONTACT
Y
YiQi Yu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here